The HOPE Asia network 2022 up-date consensus statement on morning hypertension management
Issued Date
2022-09-01
Resource Type
ISSN
15246175
eISSN
17517176
Scopus ID
2-s2.0-85139254710
Pubmed ID
36196465
Journal Title
Journal of Clinical Hypertension
Volume
24
Issue
9
Start Page
1112
End Page
1120
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Hypertension Vol.24 No.9 (2022) , 1112-1120
Suggested Citation
Kario K., Wang J.G., Chia Y.C., Wang T.D., Li Y., Siddique S., Shin J., Turana Y., Buranakitjaroen P., Chen C.H., Cheng H.M., Van Huynh M., Nailes J., Sukonthasarn A., Zhang Y., Sison J., Soenarta A.A., Park S., Sogunuru G.P., Tay J.C., Teo B.W., Tsoi K., Verma N., Hoshide S. The HOPE Asia network 2022 up-date consensus statement on morning hypertension management. Journal of Clinical Hypertension Vol.24 No.9 (2022) , 1112-1120. 1120. doi:10.1111/jch.14555 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85543
Title
The HOPE Asia network 2022 up-date consensus statement on morning hypertension management
Author's Affiliation
Severance Cardiovascular Hospital
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Shanghai Jiao Tong University School of Medicine
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Faculty of Medicine, Chiang Mai University
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
NUS Yong Loo Lin School of Medicine
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Medical Center Manila
Punjab Medical Center
Fortis Malar Hospital
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Shanghai Jiao Tong University School of Medicine
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Faculty of Medicine, Chiang Mai University
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
NUS Yong Loo Lin School of Medicine
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Medical Center Manila
Punjab Medical Center
Fortis Malar Hospital
Other Contributor(s)
Abstract
Morning hypertension is an important clinical target in the management of hypertension for perfect 24-h blood pressure (BP) control. Morning hypertension is generally categorized into two types: “morning surge” type and “sustained nocturnal and morning hypertension” type. The “morning surge” type is characterized by an exaggerated morning blood pressure surge (MBPS), and the “sustained nocturnal and morning hypertension” type with continuous hypertension from nighttime to morning (non-dipper/riser type). They can be detected by home and ambulatory blood pressure measurements (HBPM and ABPM). These two forms of morning hypertension both increase the risk of cardiovascular and renal diseases, but may occur via different pathogenic mechanisms and are associated with different conditions. Morning hypertension should be treated to achieve a morning BP level of < 135/85 mmHg, regardless of the office BP. The second target morning BP levels is < 125/75 mmHg for high-risk patients with morning hypertension and concomitant diseases. Morning hypertension is more frequently found in Asians, than in Westerners. Thus, the management of morning hypertension is especially important in Asia. The detection of morning hypertension and the individual home BP-guided treatment approach targeting morning BP in combination with ABPM, and the optimal treatment of morning hypertension would reduce cardiovascular events in Asia.